These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 16123503)
1. Electrocardiographic left ventricular hypertrophy in type 1 diabetes: prevalence and relation to coronary heart disease and cardiovascular risk factors: the Eurodiab IDDM Complications Study. Giunti S; Bruno G; Veglio M; Gruden G; Webb DJ; Livingstone S; Chaturvedi N; Fuller JH; Perin PC; Diabetes Care; 2005 Sep; 28(9):2255-7. PubMed ID: 16123503 [No Abstract] [Full Text] [Related]
2. Risk factors for coronary heart disease in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study. Soedamah-Muthu SS; Chaturvedi N; Toeller M; Ferriss B; Reboldi P; Michel G; Manes C; Fuller JH; Diabetes Care; 2004 Feb; 27(2):530-7. PubMed ID: 14747240 [TBL] [Abstract][Full Text] [Related]
3. Cardiovascular disease and its risk factors in IDDM in Europe. EURODIAB IDDM Complications Study Group. Koivisto VA; Stevens LK; Mattock M; Ebeling P; Muggeo M; Stephenson J; Idzior-Walus B Diabetes Care; 1996 Jul; 19(7):689-97. PubMed ID: 8799621 [TBL] [Abstract][Full Text] [Related]
4. Sex-differences in prevalence of electrocardiographic left ventricular hypertrophy in Type 2 diabetes: the Casale Monferrato Study. Bruno G; Giunti S; Bargero G; Ferrero S; Pagano G; Perin PC Diabet Med; 2004 Aug; 21(8):823-8. PubMed ID: 15270784 [TBL] [Abstract][Full Text] [Related]
5. Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications Study. Diabetologia; 1994 Mar; 37(3):278-85. PubMed ID: 8174842 [TBL] [Abstract][Full Text] [Related]
6. The relationship between socioeconomic status and diabetes control and complications in the EURODIAB IDDM Complications Study. Chaturvedi N; Stephenson JM; Fuller JH Diabetes Care; 1996 May; 19(5):423-30. PubMed ID: 8732703 [TBL] [Abstract][Full Text] [Related]
7. Prevalence of complications in IDDM by sex and duration. Pittsburgh Epidemiology of Diabetes Complications Study II. Orchard TJ; Dorman JS; Maser RE; Becker DJ; Drash AL; Ellis D; LaPorte RE; Kuller LH Diabetes; 1990 Sep; 39(9):1116-24. PubMed ID: 2384191 [TBL] [Abstract][Full Text] [Related]
8. [Coronary risk factors in a group of patients with insulin dependent diabetes mellitus--examination of the EURODIAB IDDM Complications Study Krakow]. Idzior-Waluś B; Solnica B; Szopinska-Ciba L; Sieradzki J Przegl Lek; 1994; 51(11):468-74. PubMed ID: 7871192 [TBL] [Abstract][Full Text] [Related]
9. Triglyceride, albuminuria and blood pressure are the major associations of non-fatal cardiovascular disease in Chinese type 2 diabetes. Ko GT; Chan JC; Chow CC; Yeung VT; Chan WB; So WY; Ma RC; Ozaki R; Cockram CS Acta Diabetol; 2003 Jun; 40(2):80-4. PubMed ID: 12861405 [TBL] [Abstract][Full Text] [Related]
10. Chronic diabetic complications in patients with MODY3 diabetes. Isomaa B; Henricsson M; Lehto M; Forsblom C; Karanko S; Sarelin L; Häggblom M; Groop L Diabetologia; 1998 Apr; 41(4):467-73. PubMed ID: 9562352 [TBL] [Abstract][Full Text] [Related]
11. Microalbuminuria is not rare before 5 years of IDDM. EURODIAB IDDM Complications Study Group and the WHO Multinational Study of Vascular Disease in Diabetes Study Group. Stephenson JM; Fuller JH J Diabetes Complications; 1994; 8(3):166-73. PubMed ID: 8086653 [TBL] [Abstract][Full Text] [Related]
12. Parental history of hypertension and parental history of diabetes and microvascular complications in insulin-dependent diabetes mellitus: the EURODIAB IDDM Complications Study. Roglic G; Colhoun HM; Stevens LK; Lemkes HH; Manes C; Fuller JH Diabet Med; 1998 May; 15(5):418-26. PubMed ID: 9609365 [TBL] [Abstract][Full Text] [Related]
14. Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy, and cardiovascular disease in NIDDM. Savage S; Estacio RO; Jeffers B; Schrier RW Diabetes Care; 1996 Nov; 19(11):1243-8. PubMed ID: 8908388 [TBL] [Abstract][Full Text] [Related]
15. Complications and cardiovascular risk factors in insulin-dependent diabetes--findings in an Irish clinic and in other European centres. Cronin CC; Ferriss JB; Stephenson JM; Crowley B; Whyte A; Cleary PE Ir J Med Sci; 1994 Nov; 163(11):496-500. PubMed ID: 7806441 [TBL] [Abstract][Full Text] [Related]
16. The dose-response effects of uric acid on the prevalence of metabolic syndrome and electrocardiographic left ventricular hypertrophy in healthy individuals. Liu CW; Chen KH; Tseng CK; Chang WC; Wu YW; Hwang JJ Nutr Metab Cardiovasc Dis; 2019 Jan; 29(1):30-38. PubMed ID: 30545672 [TBL] [Abstract][Full Text] [Related]
18. NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Alexander CM; Landsman PB; Teutsch SM; Haffner SM; ; Diabetes; 2003 May; 52(5):1210-4. PubMed ID: 12716754 [TBL] [Abstract][Full Text] [Related]
19. Recent developments in diabetes epidemiology in Europe. Fuller JH World Health Stat Q; 1992; 45(4):350-4. PubMed ID: 1299076 [TBL] [Abstract][Full Text] [Related]